Strategic Blueprint, LLC Exact Sciences Corp Transaction History

Strategic Blueprint, LLC

$1.32 Billion
Q1 2024

A detailed history of Strategic Blueprint, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Strategic Blueprint, LLC holds 5,868 shares of EXAS stock, worth $265,174. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,868

Previous 5,476 7.16%

Holding current value

$265,174

Previous $405,000 -0.0%

% of portfolio

0.03%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$56.27 - $73.77 $22,057 - $28,917	392 Added 7.16%	5,868 $405,000
Q4 2023 Jan 25, 2024	BUY	$59.06 - $75.72 $1,594 - $2,044	27 Added 0.5%	5,476 $405,000
Q3 2023 Oct 18, 2023	BUY	$65.94 - $99.04 $10,748 - $16,143	163 Added 3.08%	5,449 $371,000
Q2 2023 Oct 18, 2023	BUY	$62.68 - $95.05 $31,340 - $47,525	500 Added 10.45%	5,286 $496,000
Q4 2022 Jan 26, 2023	BUY	$30.35 - $53.15 $145,255 - $254,375	4,786 New	4,786 $0

Q2 2022 Aug 12, 2022	SELL	$35.61 - $76.23 $171,426 - $366,971	-4,814 Closed	0 $0
Q1 2022 Aug 12, 2022	SELL	$57.56 - $82.54 $17,555 - $25,174	-305 Reduced 5.96%	4,814 $337,000
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $3,625 - $5,034	50 Added 0.99%	5,119 $398,000
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $47,827 - $65,746	530 Added 11.68%	5,069 $484,000
Q2 2021 Aug 12, 2021	BUY	$93.66 - $139.27 $39,430 - $58,632	421 Added 10.22%	4,539 $564,000
Q1 2021 May 10, 2021	SELL	$116.57 - $155.01 $6,644 - $8,835	-57 Reduced 1.37%	4,118 $543,000
Q3 2020 Oct 27, 2020	BUY	$72.92 - $102.01 $20,053 - $28,052	275 Added 7.05%	4,175 $426,000
Q2 2020 Jul 20, 2020	BUY	$55.75 - $92.75 $15,164 - $25,228	272 Added 7.5%	3,900 $339,000
Q1 2020 Apr 20, 2020	BUY	$37.9 - $104.44 $3,790 - $10,444	100 Added 2.83%	3,628 $210,000
Q4 2019 Jan 10, 2020	BUY	$77.66 - $99.74 $231,038 - $296,726	2,975 Added 537.97%	3,528 $326,000
Q3 2019 Oct 16, 2019	BUY	$90.37 - $122.49 $49,974 - $67,736	553 New	553 $50,000

Others Institutions Holding EXAS

# of Institutions

700

Shares Held

160M

Call Options Held

5.84M

Put Options Held

2.58M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.

Account

Strategic Blueprint, LLC Exact Sciences Corp Transaction History